Vertex Rail Technologies opened in Wilmington in 2014 with promises of over 1,300 jobs and a $60 million investment. Despite initial optimism and orders, the company faced setbacks including ...

Cheng Xin / Getty Images Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped. The biotech firm also posted a decline in sales outside the U.S. because of ...

You can reach Jason on Signal at JasonMast.05. Vertex Pharmaceuticals on Monday reported disappointing first-quarter earnings impacted by weaker-than-expected sales of its drugs for cystic ...

SpaceX's Starlink is offering new residential customers of its satellite internet service its $349 hardware kit for free. But it's not free for everyone, and there are some caveats. In a post on ...

Making it Easier for Developers of All Skill Levels to Build AI Meanwhile, the Agent Development Kit (ADK), agent engine, and other advances in the Vertex AI platform help bootstrap the ...

However, Google said its new Agent Development Kit (ADK) and other additional capabilities ... ADK is optimized for Gemini models, though Vertex AI allows access to models from Anthropic, Meta ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

At the 2025 Napa Valley Biotech Forum, JPMorgan analyst Jessica Fye walked away with a bullish tone after conversations with Vertex CEO Reshma Kewalramani and Senior Vice President of Investor ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

Here’s how it works. Every driver should have one of the best emergency car kits somewhere in their car. Driving is a risky business, and there's plenty of opportunity for things top go wrong.

Goldman Sachs analyst reiterates Buy on Vertex, with a $48 target, expecting strong, sustainable growth and macro resilience. Analyst anticipates focus on demand sustainability, e-invoicing ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...